Biologics Compliance Guide for Germany

This is a compliance guide for clinics that want to operate in Germany.

Key Pieces of Legislation:

Embryo Protection Act (Embryonenschutzgesetz - ESchG)

Enacted in 1990, this act regulates the handling of human embryos and gametes, prohibiting the derivation of embryonic stem cells from human embryos.

Stem Cell Act (Stammzellgesetz - StZG)

Enacted in 2002, this act gives priority to the use of adult stem cells and regulates the importation of embryonic stem cell lines under strict conditions.

Federal Institute for Drugs and Medical Devices (BfArM)

This institute regulates the approval and marketing of stem cell therapies, ensuring compliance with safety and efficacy standards

Paul Ehrlich Institute (PEI)

This institute oversees the regulation of advanced therapy medicinal products (ATMPs), including stem cell therapies.

Central Ethics Commission for Stem Cell Research (ZES)

This commission reviews applications to import stem cell lines for research and ensures ethical oversight.

Embryo Protection Act (1990)

This act heavily restricts the use of embryos for research and makes the derivation of embryonic stem cell lines a criminal offense. Violations of this act can lead to legal action.

Stem Cell Act (2002)

This act gives priority to the use of adult stem cells and regulates the importation of embryonic stem cell lines under strict conditions. Non-compliance with this act can result in legal consequences.

Compliance Checklist

Compliance with the Stem Cell Act (Stammzellgesetz):

Ensure adherence to the 2002 Stem Cell Act, which prioritizes the use of adult stem cells and regulates the importation of embryonic stem cell lines under strict conditions.

Approval from Regulatory Bodies:

Obtain approval from the Federal Institute for Drugs and Medical Devices (BfArM) for the use of stem cell therapies.

Ensure compliance with the Paul Ehrlich Institute (PEI) regulations for advanced therapy medicinal products (ATMPs).

Ethical Approval:

Obtain approval from ethics committees for any stem cell therapy studies involving human subjects.

Informed Consent:

Obtain informed consent from patients, clearly explaining the potential risks, benefits, and alternatives to the treatment.

Proper Handling and Storage:

Follow proper protocols for the handling, storage, and administration of stem cells to maintain their viability and safety.

Documentation and Record-Keeping:

Maintain detailed records of all stem cell treatments, including patient consent forms, treatment protocols, and outcomes.

Patient Safety and Monitoring:

Implement safety measures and monitoring protocols to track patient responses and manage any adverse effects.

Insurance and Liability:

Ensure that the clinic has appropriate insurance coverage for stem cell treatments and is aware of potential liability issues.

Stay Updated on Legal Changes:

Regularly review and stay informed about any changes in federal, state, and local regulations regarding stem cell treatments.

Who can administer

Doctors (General Practitioners and Specialists): Physicians with appropriate licenses who are trained in regenerative medicine and stem cell therapies.

Nurses: Registered nurses who are certified and licensed to assist in the administration of exosome treatments under the supervision of a licensed physician.

Pharmacists: Licensed pharmacists who can dispense exosome products in accordance with regulatory guidelines.

Medical Assistants: Certified medical assistants who work under the supervision of licensed healthcare professionals.

Source Info

State Regulations

Select a state:

The purpose of this website is to provide information for on protocols and general information about biologics, including the regulations and basic information.

Select a country:

The purpose of this website is to provide information for on protocols and general information about biologics, including the regulations and basic information.

Search our site

About

Our mission is to equip practitioners with essential knowledge on biologics, covering protocols, regulatory guidelines, and foundational insights. This site serves as a trusted resource for navigating the evolving landscape of stem cell applications in clinical practice.

Disclaimer

The information on this website is provided solely for informational purposes and has not been reviewed or approved by the FDA or any other regulatory authority. It does not constitute medical advice, diagnosis, treatment, or any guarantees of medical outcomes and should not be used as a substitute for formal medical education and training, nor as a substitute for consultation with qualified healthcare professionals. Similarly, the content does not provide legal advice or guidance on regulatory compliance and should not replace consultations with qualified legal professionals.

DiscoverBiologics.com makes no representations or warranties, express or implied, regarding the accuracy, reliability, or applicability of the information provided to individual health circumstances or the legal use and adoption of biological products by clinics or providers.

By accessing this website, you agree to the terms and conditions outlined herein and accept full responsibility for compliance and clinical decisions made within your practice. You also acknowledge that you have been encouraged to review the disclaimer page and understand that any reliance on the information provided is voluntary and at your own risk and sole discretion.

2025 © All Rights Reserved. DiscoverBiologics.com